Search results
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 46 minutes ago(NASDAQ: GRTS) securities between March 9, 2023 and February 29, 2024. Gritstone is a clinical-stage biotechnology company that engages in developing vaccine-based immunotherapy< ...
Dual Immunotherapy Improves Response Rates in Gynecologic Clear Cell Cancers
MedPage Today· 5 days agoAt a median follow-up of 11.3 months, the overall response rate (ORR) among the 30 patients who...
Two-pronged attack strategy boosts immunotherapy i | Newswise
Newswise· 6 days agoA novel immunotherapy approach developed by Ludwig Cancer Research scientists employs a two-pronged...
Immunotherapy before surgery very successful in treating colorectal cancer, trial finds
Medical Xpress· 3 days agoPatients with colon cancer with a specific genetic makeup, known as mismatch-repair deficient (dMMR) or microsatellite instable (MSI), were treated with one cycle of ipilimumab and two cycles ...
AI tool helps determine if immunotherapy drugs are effective for treating a patient’s cancer
National Cancer Institute· 6 days agoIn a proof-of-concept study, researchers at the National Institutes of Health (NIH) have developed...
Phase 2 Study Shows Opdivo-Yervoy Highly Effective In Colon Cancer
Forbes· 2 days agoA four-week course of dual immunotherapy prior to surgery is highly effective in treating a certain...
How tumor stiffness alters immune cell behavior to | Newswise
Newswise· 5 days agoImmunotherapy is based on harnessing a person’s own immune system to attack cancer cells. “The full...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 5 days agoMerck and Moderna released “extremely impressive” positive data from a mid-stage trial of the...
Immunotherapy bowel cancer drug works for 100% of patients – researchers
Press Association News via AOL· 6 days agoJemperli – also called dostarlimab – from GSK showed ‘unprecedented results’, the firm said, with no...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 5 days agoMelanoma patients who received monthly mRNA vaccines and Merck’s Keytruda immunotherapy had lower...